I. Ocaña

Review: circulating tumor cells in the practice of breast cancer oncology

M. Martín, J. García-Saenz, F. Moreno, 2016, Clinical and Translational Oncology.

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

C. Perou, K. Hoadley, A. Picornell, 2019, BMC Genomics.

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

A. Picornell, H. Gómez, J. García-Saenz, 2016, Breast Cancer Research and Treatment.

Concordance of Genomic Variants in Matched Primary Breast Cancer, Metastatic Tumor, and Circulating Tumor DNA: The MIRROR Study.

A. Picornell, J. García-Saenz, F. Moreno, 2019, JCO precision oncology.

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

C. Perou, K. Hoadley, A. Picornell, 2019, BMC Genomics.

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

C. Perou, K. Hoadley, A. Picornell, 2018, Clinical Cancer Research.

85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study

M. Cebollero, I. Márquez-Rodas, J. G. García Sáenz, 2022, Annals of Oncology.

Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.

J. García-Saenz, M. Cebollero, I. Márquez-Rodas, 2023, Breast Cancer Research and Treatment.